Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Influenza
Meningococcal disease
2021
2015
Europe
Clear all
Type of publications
NITAG documentation
(84)
Systematic reviews (SYSVAC)
(4)
Topics
Available to download in languages
Regions
Europe
(88)
Africa
(20)
Americas
(78)
South-East Asia
(2)
Western Pacific
(17)
Countries
Belgium
(16)
Denmark
(1)
France
(19)
Germany
(10)
Ireland
(7)
Luxembourg
(1)
Netherlands
(6)
Spain
(1)
Sweden
(2)
Switzerland
(2)
United Kingdom
(20)
Diseases
COVID-19
(76)
Influenza
(9)
Meningococcal disease
(5)
Haemophilus influenzae type B
(2)
Hepatitis A
(3)
Hepatitis B
(3)
Human papillomavirus (HPV)
(5)
Measles
(2)
Pertussis
(3)
Pneumococcal disease
(5)
Poliomyelitis
(2)
Rotavirus
(4)
Varicella
(1)
Yellow fever
(1)
Vaccine topics
Acceptance
(3)
Coverage
(3)
Ethical issues
(1)
Target population
Adolescents
(2)
Adults
(3)
All age groups
(1)
Older adults
(2)
Parents/caregivers
(1)
Pregnant women
(2)
Risk group
(2)
Publication date
2021
(78)
2015
(10)
2024
(1)
2023
(19)
2022
(40)
2020
(20)
2019
(15)
2018
(12)
2017
(10)
2016
(5)
2014
(13)
2013
(6)
2012
(2)
2011
(7)
2010
(20)
2009
(8)
2007
(3)
2006
(3)
2005
(2)
2001
(1)
2000
(1)
88 results found
2021
∙
NIAC
Updated recommendations regarding selection, dose and timing of booster doses of COVID-19 vaccine for those aged 60 years and over
2021
∙
JCVI
Use of the AstraZeneca COVID-19 (AZD1222) vaccine: updated JCVI statement, 7 May 2021
2021
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 in pregnant and breastfeeding women
2021
∙
Haute Autorité de Santé, Commission Technique des Vaccinations
Vaccination of people with a history of Covid-19
2021
∙
Commission Technique des Vaccinations, Haute Autorité de Santé
Vaccination strategy against Covid-19 - AstraZeneca vaccine
2021
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19 - Janssen COVID-19 vaccine
2021
∙
Commission Technique des Vaccinations, Haute Autorité de Santé
Vaccination strategy against Covid-19 - the Moderna Covid-19 mRNA (nucleoside modified) vaccine
2021
Vaccination strategy against COVID19 in Spain
2015
∙
Malerba, V. Costantino, C. Napoli, G. Marchese, V. Casuccio, A. Tabacchi, G. Vitale, F.
Antimeningococcal and antipneumococcal vaccination determinants: a European systematic literature review
2015
∙
STIKO
Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register